AU2002213755A1 - A vaccine for acids and its preparation and use - Google Patents

A vaccine for acids and its preparation and use

Info

Publication number
AU2002213755A1
AU2002213755A1 AU2002213755A AU1375502A AU2002213755A1 AU 2002213755 A1 AU2002213755 A1 AU 2002213755A1 AU 2002213755 A AU2002213755 A AU 2002213755A AU 1375502 A AU1375502 A AU 1375502A AU 2002213755 A1 AU2002213755 A1 AU 2002213755A1
Authority
AU
Australia
Prior art keywords
vaccine
acids
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213755A
Inventor
Yinghua Chen
Jian Ding
Yun Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING GUOXIWEIYE HIGH TECHNOLOGY DEVELOPMENT Co Ltd
JIANGXI DRAGON-FIY SCIENCE AND Technologies Co Ltd
Tsinghua University
Original Assignee
BEIJING GUOXIWEIYE HIGH TECHNO
JIANGXI DRAGON FIY SCIENCE AND
Tsinghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING GUOXIWEIYE HIGH TECHNO, JIANGXI DRAGON FIY SCIENCE AND, Tsinghua University filed Critical BEIJING GUOXIWEIYE HIGH TECHNO
Publication of AU2002213755A1 publication Critical patent/AU2002213755A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2002213755A 2000-08-18 2001-07-20 A vaccine for acids and its preparation and use Abandoned AU2002213755A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN00123487A CN1339320A (en) 2000-08-18 2000-08-18 AIDS vacuum and its preparing method and use
CN00123487 2000-08-18
PCT/CN2001/001190 WO2002026253A1 (en) 2000-08-18 2001-07-20 A vaccine for acids and its preparation and use

Publications (1)

Publication Number Publication Date
AU2002213755A1 true AU2002213755A1 (en) 2002-04-08

Family

ID=4589907

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213755A Abandoned AU2002213755A1 (en) 2000-08-18 2001-07-20 A vaccine for acids and its preparation and use

Country Status (3)

Country Link
CN (1) CN1339320A (en)
AU (1) AU2002213755A1 (en)
WO (1) WO2002026253A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005076001A2 (en) * 2004-02-06 2005-08-18 Inserm (Institut National De La Sante Et De La Recherche Medicale) A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
DE102004005186B3 (en) * 2004-02-02 2005-10-13 Krka Tovarna Zdravil, D.D. Process for the preparation of purified ciprofloxacin
CN101914143A (en) * 2010-08-19 2010-12-15 清华大学 HIV-1 membrane fusion inhibitor and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013548A (en) * 1987-09-08 1991-05-07 Duke University Production of antibodies to HIV
FR2671554A1 (en) * 1991-01-11 1992-07-17 Clonatec Sa HEPATITIS B VIRUS-BASED HBC ANTIGEN SYNTHETIC PEPTIDES, THEIR USE IN THE DETECTION OF VIRUS INFECTION AND VACCINATION AGAINST HEPATITIS B.
IT1254360B (en) * 1992-05-11 1995-09-14 San Romanello Centro Fond IMMUNOLOGICALLY HOMOLOGICAL EPITOPES OF HLA AND VIRUS HIV PROTEINS.
WO1995005851A1 (en) * 1993-08-20 1995-03-02 St. Luke's-Roosevelt Hospital Center HIV vif-RELATED COMPOSITIONS, AND PROPHYLACTIC AND THERAPEUTIC USES THEREOF
US7018637B2 (en) * 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines

Also Published As

Publication number Publication date
CN1339320A (en) 2002-03-13
WO2002026253A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2002336760A1 (en) Mutable vaccines
PL392363A1 (en) Vaccine formulation
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU1591402A (en) Vaccine
AU2001235506A1 (en) Dermatological use and a dermatological preparation
AU2001273761A1 (en) Preparation of (r)-2-alkyl-3-phenylpropionic acids
AU2002214978A1 (en) Beta-Thio-amino acids
GB0014288D0 (en) Vaccine
AU5977700A (en) Vaccines
AU2001273644A1 (en) Disposable mattress portion
AUPQ948800A0 (en) A vaccine strategy
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AU6158700A (en) Vaccine
AUPR030800A0 (en) Immunomodulatory preparation
AU2001278323A1 (en) Modified sialic acid vaccines
AU2002213755A1 (en) A vaccine for acids and its preparation and use
AU2002249823A1 (en) Acne vaccine
AU2001241187A1 (en) Sustained release oral preparations
AU2002222139A1 (en) Hcv vaccines
AU2001253658A1 (en) A glycopeptide and preparation thereof
AU5811600A (en) Vaccine
AU2001257100A1 (en) Nalpha, nomega-dialkyl aminomethylenephosphonic acids and use thereof
AU2002223398A1 (en) A vaccine for influenza virus and its preparation
AU2001288795A1 (en) Eia vaccine and diagnostic
AU2001291202A1 (en) Avian pneumovirus vaccine